Clinical trial
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00393718 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00393718 |
|---|---|
| Title | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes |
| Official title | Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | liraglutide, glibenclamide, placebo |
| Enrollment | 400 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Oct 30, 2006 |
| Last update posted | Mar 8, 2017 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: